Johnson & Johnson Enters US Robotic Surgery Market with Ottava System Johnson & Johnson has secured FDA marketing authorization for its Ottava robotic surgical system, paving the way for the company to enter the lucrative US market for robotic assisted surgery.
The healthcare giant's entry into this space marks a significant challenge to Intuitive Surgical's dominance with its da Vinci system.
Ottava's smaller footprint and integrated design may give it an edge over more cumbersome systems. According to Hani Abouhalka, chairman of surgery at J&J MedTech, "Our intention is to lead in surgical robotics.